United States Human Embryonic Stem Cells (HESC) Industry 2017 Market Research Report

Published: Apr, 2017 | Pages: 111 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the United States Human Embryonic Stem Cells (HESC) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Human Embryonic Stem Cells (HESC) in these regions, from 2012 to 2022 (forecast).

United States Human Embryonic Stem Cells (HESC) market competition by top manufacturers/players, with Human Embryonic Stem Cells (HESC) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Astellas Pharma Inc/ Ocata Therapeutics
    STEMCELL Technologies
    BIOTIME, INC
    Thermo Fisher Scientific
    CellGenix
    ESI BIO
    PromoCell
    Lonza
    Kite Pharma
    Cynata
    Sumanas
    LifeCell
    Geron
    Millipore
    BD Biosciences
    Genea BioCells

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Adult Sources
    Fetal Sources
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Human Embryonic Stem Cells (HESC) for each application, including
    Regenerative Medicine
    Stem Cell Biology Research
    Tissue Engineering
    Toxicology Testing

 Table of Contents

United States Human Embryonic Stem Cells (HESC) Market Report 2017
1 Human Embryonic Stem Cells (HESC) Overview
    1.1 Product Overview and Scope of Human Embryonic Stem Cells (HESC)
    1.2 Classification of Human Embryonic Stem Cells (HESC) by Product Category
        1.2.1 United States Human Embryonic Stem Cells (HESC) Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Human Embryonic Stem Cells (HESC) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Adult Sources
        1.2.4 Fetal Sources
    1.3 United States Human Embryonic Stem Cells (HESC) Market by Application/End Users
        1.3.1 United States Human Embryonic Stem Cells (HESC) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Regenerative Medicine
        1.3.3 Stem Cell Biology Research
        1.3.4 Tissue Engineering
        1.3.5 Toxicology Testing
    1.4 United States Human Embryonic Stem Cells (HESC) Market by Region
        1.4.1 United States Human Embryonic Stem Cells (HESC) Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Human Embryonic Stem Cells (HESC) Status and Prospect (2012-2022)
        1.4.3 Southwest Human Embryonic Stem Cells (HESC) Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Human Embryonic Stem Cells (HESC) Status and Prospect (2012-2022)
        1.4.5 New England Human Embryonic Stem Cells (HESC) Status and Prospect (2012-2022)
        1.4.6 The South Human Embryonic Stem Cells (HESC) Status and Prospect (2012-2022)
        1.4.7 The Midwest Human Embryonic Stem Cells (HESC) Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Human Embryonic Stem Cells (HESC) (2012-2022)
        1.5.1 United States Human Embryonic Stem Cells (HESC) Sales and Growth Rate (2012-2022)
        1.5.2 United States Human Embryonic Stem Cells (HESC) Revenue and Growth Rate (2012-2022)

2 United States Human Embryonic Stem Cells (HESC) Market Competition by Players/Suppliers
    2.1 United States Human Embryonic Stem Cells (HESC) Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Human Embryonic Stem Cells (HESC) Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Human Embryonic Stem Cells (HESC) Average Price by Players/Suppliers (2012-2017)
    2.4 United States Human Embryonic Stem Cells (HESC) Market Competitive Situation and Trends
        2.4.1 United States Human Embryonic Stem Cells (HESC) Market Concentration Rate
        2.4.2 United States Human Embryonic Stem Cells (HESC) Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Human Embryonic Stem Cells (HESC) Manufacturing Base Distribution, Sales Area, Product Type

3 United States Human Embryonic Stem Cells (HESC) Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Human Embryonic Stem Cells (HESC) Sales and Market Share by Region (2012-2017)
    3.2 United States Human Embryonic Stem Cells (HESC) Revenue and Market Share by Region (2012-2017)
    3.3 United States Human Embryonic Stem Cells (HESC) Price by Region (2012-2017)

4 United States Human Embryonic Stem Cells (HESC) Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Human Embryonic Stem Cells (HESC) Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Human Embryonic Stem Cells (HESC) Revenue and Market Share by Type (2012-2017)
    4.3 United States Human Embryonic Stem Cells (HESC) Price by Type (2012-2017)
    4.4 United States Human Embryonic Stem Cells (HESC) Sales Growth Rate by Type (2012-2017)

5 United States Human Embryonic Stem Cells (HESC) Sales (Volume) by Application (2012-2017)
    5.1 United States Human Embryonic Stem Cells (HESC) Sales and Market Share by Application (2012-2017)
    5.2 United States Human Embryonic Stem Cells (HESC) Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Human Embryonic Stem Cells (HESC) Players/Suppliers Profiles and Sales Data
    6.1 Astellas Pharma Inc/ Ocata Therapeutics
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Human Embryonic Stem Cells (HESC) Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Astellas Pharma Inc/ Ocata Therapeutics Human Embryonic Stem Cells (HESC) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 STEMCELL Technologies
        6.2.2 Human Embryonic Stem Cells (HESC) Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 BIOTIME, INC
        6.3.2 Human Embryonic Stem Cells (HESC) Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 BIOTIME, INC Human Embryonic Stem Cells (HESC) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Thermo Fisher Scientific
        6.4.2 Human Embryonic Stem Cells (HESC) Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Thermo Fisher Scientific Human Embryonic Stem Cells (HESC) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 CellGenix
        6.5.2 Human Embryonic Stem Cells (HESC) Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 CellGenix Human Embryonic Stem Cells (HESC) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 ESI BIO
        6.6.2 Human Embryonic Stem Cells (HESC) Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 ESI BIO Human Embryonic Stem Cells (HESC) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 PromoCell
        6.7.2 Human Embryonic Stem Cells (HESC) Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 PromoCell Human Embryonic Stem Cells (HESC) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Lonza
        6.8.2 Human Embryonic Stem Cells (HESC) Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Lonza Human Embryonic Stem Cells (HESC) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Kite Pharma
        6.9.2 Human Embryonic Stem Cells (HESC) Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Kite Pharma Human Embryonic Stem Cells (HESC) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Cynata
        6.10.2 Human Embryonic Stem Cells (HESC) Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Cynata Human Embryonic Stem Cells (HESC) Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Sumanas
    6.12 LifeCell
    6.13 Geron
    6.14 Millipore
    6.15 BD Biosciences
    6.16 Genea BioCells

7 Human Embryonic Stem Cells (HESC) Manufacturing Cost Analysis
    7.1 Human Embryonic Stem Cells (HESC) Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Human Embryonic Stem Cells (HESC)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Human Embryonic Stem Cells (HESC) Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Human Embryonic Stem Cells (HESC) Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Human Embryonic Stem Cells (HESC) Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Human Embryonic Stem Cells (HESC) Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Human Embryonic Stem Cells (HESC) Sales Volume Forecast by Type (2017-2022)
    11.3 United States Human Embryonic Stem Cells (HESC) Sales Volume Forecast by Application (2017-2022)
    11.4 United States Human Embryonic Stem Cells (HESC) Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Human Embryonic Stem Cells (HESC)
    Figure United States Human Embryonic Stem Cells (HESC) Market Size (K Units) by Type (2012-2022)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Volume Market Share by Type (Product Category) in 2016
    Figure Adult Sources Product Picture
    Figure Fetal Sources Product Picture
    Figure United States Human Embryonic Stem Cells (HESC) Market Size (K Units) by Application (2012-2022)
    Figure United States Sales Market Share of Human Embryonic Stem Cells (HESC) by Application in 2016
    Figure Regenerative Medicine Examples
    Figure Stem Cell Biology Research Examples
    Figure Tissue Engineering Examples
    Figure Toxicology Testing Examples
    Figure United States Human Embryonic Stem Cells (HESC) Market Size (Million USD) by Region (2012-2022)
    Figure The West Human Embryonic Stem Cells (HESC) Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southwest Human Embryonic Stem Cells (HESC) Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Middle Atlantic Human Embryonic Stem Cells (HESC) Revenue (Million USD) and Growth Rate (2012-2022)
    Figure New England Human Embryonic Stem Cells (HESC) Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The South of US Human Embryonic Stem Cells (HESC) Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Midwest Human Embryonic Stem Cells (HESC) Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Human Embryonic Stem Cells (HESC) Sales (K Units) and Growth Rate (2012-2022)
    Figure United States Human Embryonic Stem Cells (HESC) Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Human Embryonic Stem Cells (HESC) Market Major Players Product Sales Volume (K Units) (2012-2017)
    Table United States Human Embryonic Stem Cells (HESC) Sales (K Units) of Key Players/Suppliers (2012-2017)
    Table United States Human Embryonic Stem Cells (HESC) Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Human Embryonic Stem Cells (HESC) Sales Share by Players/Suppliers
    Figure 2017 United States Human Embryonic Stem Cells (HESC) Sales Share by Players/Suppliers
    Figure United States Human Embryonic Stem Cells (HESC) Market Major Players Product Revenue (Million USD) (2012-2017)
    Table United States Human Embryonic Stem Cells (HESC) Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table United States Human Embryonic Stem Cells (HESC) Revenue Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Human Embryonic Stem Cells (HESC) Revenue Share by Players/Suppliers
    Figure 2017 United States Human Embryonic Stem Cells (HESC) Revenue Share by Players/Suppliers
    Table United States Market Human Embryonic Stem Cells (HESC) Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
    Figure United States Market Human Embryonic Stem Cells (HESC) Average Price (USD/Unit) of Key Players/Suppliers in 2016
    Figure United States Human Embryonic Stem Cells (HESC) Market Share of Top 3 Players/Suppliers
    Figure United States Human Embryonic Stem Cells (HESC) Market Share of Top 5 Players/Suppliers
    Table United States Players/Suppliers Human Embryonic Stem Cells (HESC) Manufacturing Base Distribution and Sales Area
    Table United States Players/Suppliers Human Embryonic Stem Cells (HESC) Product Category
    Table United States Human Embryonic Stem Cells (HESC) Sales (K Units) by Region (2012-2017)
    Table United States Human Embryonic Stem Cells (HESC) Sales Share by Region (2012-2017)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Share by Region (2012-2017)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Market Share by Region in 2016
    Table United States Human Embryonic Stem Cells (HESC) Revenue (Million USD) and Market Share by Region (2012-2017)
    Table United States Human Embryonic Stem Cells (HESC) Revenue Share by Region (2012-2017)
    Figure United States Human Embryonic Stem Cells (HESC) Revenue Market Share by Region (2012-2017)
    Figure United States Human Embryonic Stem Cells (HESC) Revenue Market Share by Region in 2016
    Table United States Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Region (2012-2017)
    Table United States Human Embryonic Stem Cells (HESC) Sales (K Units) by Type (2012-2017)
    Table United States Human Embryonic Stem Cells (HESC) Sales Share by Type (2012-2017)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Share by Type (2012-2017)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Market Share by Type in 2016
    Table United States Human Embryonic Stem Cells (HESC) Revenue  (Million USD) and Market Share by Type (2012-2017)
    Table United States Human Embryonic Stem Cells (HESC) Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Human Embryonic Stem Cells (HESC) by Type (2012-2017)
    Figure Revenue Market Share of Human Embryonic Stem Cells (HESC) by Type in 2016
    Table United States Human Embryonic Stem Cells (HESC) Price (USD/Unit) by Types (2012-2017)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Growth Rate by Type (2012-2017)
    Table United States Human Embryonic Stem Cells (HESC) Sales (K Units) by Application (2012-2017)
    Table United States Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2012-2017)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Market Share by Application (2012-2017)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Market Share by Application in 2016
    Table United States Human Embryonic Stem Cells (HESC) Sales Growth Rate by Application (2012-2017)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Growth Rate by Application (2012-2017)
    Table Astellas Pharma Inc/ Ocata Therapeutics Basic Information List
    Table Astellas Pharma Inc/ Ocata Therapeutics Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Astellas Pharma Inc/ Ocata Therapeutics Human Embryonic Stem Cells (HESC) Sales Growth Rate (2012-2017)
    Figure Astellas Pharma Inc/ Ocata Therapeutics Human Embryonic Stem Cells (HESC) Sales Market Share in United States (2012-2017)
    Figure Astellas Pharma Inc/ Ocata Therapeutics Human Embryonic Stem Cells (HESC) Revenue Market Share in United States (2012-2017)
    Table STEMCELL Technologies Basic Information List
    Table STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales Growth Rate (2012-2017)
    Figure STEMCELL Technologies Human Embryonic Stem Cells (HESC) Sales Market Share in United States (2012-2017)
    Figure STEMCELL Technologies Human Embryonic Stem Cells (HESC) Revenue Market Share in United States (2012-2017)
    Table BIOTIME, INC Basic Information List
    Table BIOTIME, INC Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure BIOTIME, INC Human Embryonic Stem Cells (HESC) Sales Growth Rate (2012-2017)
    Figure BIOTIME, INC Human Embryonic Stem Cells (HESC) Sales Market Share in United States (2012-2017)
    Figure BIOTIME, INC Human Embryonic Stem Cells (HESC) Revenue Market Share in United States (2012-2017)
    Table Thermo Fisher Scientific Basic Information List
    Table Thermo Fisher Scientific Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Thermo Fisher Scientific Human Embryonic Stem Cells (HESC) Sales Growth Rate (2012-2017)
    Figure Thermo Fisher Scientific Human Embryonic Stem Cells (HESC) Sales Market Share in United States (2012-2017)
    Figure Thermo Fisher Scientific Human Embryonic Stem Cells (HESC) Revenue Market Share in United States (2012-2017)
    Table CellGenix Basic Information List
    Table CellGenix Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure CellGenix Human Embryonic Stem Cells (HESC) Sales Growth Rate (2012-2017)
    Figure CellGenix Human Embryonic Stem Cells (HESC) Sales Market Share in United States (2012-2017)
    Figure CellGenix Human Embryonic Stem Cells (HESC) Revenue Market Share in United States (2012-2017)
    Table ESI BIO Basic Information List
    Table ESI BIO Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure ESI BIO Human Embryonic Stem Cells (HESC) Sales Growth Rate (2012-2017)
    Figure ESI BIO Human Embryonic Stem Cells (HESC) Sales Market Share in United States (2012-2017)
    Figure ESI BIO Human Embryonic Stem Cells (HESC) Revenue Market Share in United States (2012-2017)
    Table PromoCell Basic Information List
    Table PromoCell Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure PromoCell Human Embryonic Stem Cells (HESC) Sales Growth Rate (2012-2017)
    Figure PromoCell Human Embryonic Stem Cells (HESC) Sales Market Share in United States (2012-2017)
    Figure PromoCell Human Embryonic Stem Cells (HESC) Revenue Market Share in United States (2012-2017)
    Table Lonza Basic Information List
    Table Lonza Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Lonza Human Embryonic Stem Cells (HESC) Sales Growth Rate (2012-2017)
    Figure Lonza Human Embryonic Stem Cells (HESC) Sales Market Share in United States (2012-2017)
    Figure Lonza Human Embryonic Stem Cells (HESC) Revenue Market Share in United States (2012-2017)
    Table Kite Pharma Basic Information List
    Table Kite Pharma Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Kite Pharma Human Embryonic Stem Cells (HESC) Sales Growth Rate (2012-2017)
    Figure Kite Pharma Human Embryonic Stem Cells (HESC) Sales Market Share in United States (2012-2017)
    Figure Kite Pharma Human Embryonic Stem Cells (HESC) Revenue Market Share in United States (2012-2017)
    Table Cynata Basic Information List
    Table Cynata Human Embryonic Stem Cells (HESC) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Cynata Human Embryonic Stem Cells (HESC) Sales Growth Rate (2012-2017)
    Figure Cynata Human Embryonic Stem Cells (HESC) Sales Market Share in United States (2012-2017)
    Figure Cynata Human Embryonic Stem Cells (HESC) Revenue Market Share in United States (2012-2017)
    Table Sumanas Basic Information List
    Table LifeCell Basic Information List
    Table Geron Basic Information List
    Table Millipore Basic Information List
    Table BD Biosciences Basic Information List
    Table Genea BioCells Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Human Embryonic Stem Cells (HESC)
    Figure Manufacturing Process Analysis of Human Embryonic Stem Cells (HESC)
    Figure Human Embryonic Stem Cells (HESC) Industrial Chain Analysis
    Table Raw Materials Sources of Human Embryonic Stem Cells (HESC) Major Players/Suppliers in 2016
    Table Major Buyers of Human Embryonic Stem Cells (HESC)
    Table Distributors/Traders List
    Figure United States Human Embryonic Stem Cells (HESC) Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
    Figure United States Human Embryonic Stem Cells (HESC) Revenue  (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Human Embryonic Stem Cells (HESC) Price (USD/Unit) Trend Forecast (2017-2022)
    Table United States Human Embryonic Stem Cells (HESC) Sales Volume (K Units) Forecast by Type (2017-2022)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Volume (K Units) Forecast by Type (2017-2022)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Volume (K Units) Forecast by Type in 2022
    Table United States Human Embryonic Stem Cells (HESC) Sales Volume (K Units) Forecast by Application (2017-2022)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Volume (K Units) Forecast by Application (2017-2022)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Volume (K Units) Forecast by Application in 2022
    Table United States Human Embryonic Stem Cells (HESC) Sales Volume (K Units) Forecast by Region (2017-2022)
    Table United States Human Embryonic Stem Cells (HESC) Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Human Embryonic Stem Cells (HESC) Sales Volume Share Forecast by Region in 2022
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.